Expenditure incurred for Covid vaccine for HCWs, FLWs is Rs 480 cr: Choubey

The expenditure to be incurred as operational cost for Covid-19 vaccination of healthcare and frontline workers is about Rs 480 cr, Minister of State for Health Ashwini Choubey said

Vaccination, Coronavirus vaccine
Press Trust of India New Delhi
2 min read Last Updated : Mar 08 2021 | 8:55 PM IST

The expenditure to be incurred as operational cost for COVID-19 vaccination of estimated three crore healthcare and frontline workers is about Rs 480 crore and vaccines' cost is about Rs 1,392 crore, Minister of State for Health Ashwini Choubey told the Rajya Sabha on Monday.

In response to a question on whether the government plans to distribute the vaccine free of cost to any section of population in the country, the minister said, "Presently, the vaccine is being provided free of cost to healthcare workers and frontline workers."

As on February 4, a total of 96.28 lakh healthcare workers and 78.51 lakh frontline workers have been identified for COVID-19 vaccination, he saidin a written reply.

The database offrontline workers is in the process of getting updated on the Co-Win digital platform, he said.

"The expenditure to be incurred as operational cost for vaccination of estimated 3 crore healthcare workers and frontline workers is about Rs 480 crore and vaccines cost is about Rs 1392.82 crore," Choubey said.

Two COVID-19 vaccines -- Covishield manufactured by Serum Institute of India and Covaxin manufactured by Bharat Biotech International Limited -- have been granted permission for restricted use in emergency situation by the Drug Controller General of India (DCGI) so far.

These two vaccines have been procured for COVID-19 vaccination drive in the country which began on January 16.

Till January 26, a total of 200 lakh doses of Covishield and 28.03 lakh doses of Covaxin have been supplied, Choubey said.

The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) provides guidance on all aspects of vaccination including prioritisation of population groups for vaccination.

The NEGVAC has prioritised healthcare and frontline workers during the initial phase of COVID-19 vaccination followed by prioritized population groups of persons aged 50 years and above, and those aged less than 50 years with comorbidities.

Presently, the vaccine is being provided free of cost to healthcare and frontline workers, Choubey said.

The budget allocation of Rs 480 crore has been made for meeting the operational cost for COVID-19 vaccination of healthcare and frontline workers, in addition to the cost of the vaccines, Choubey said.

Further, in the Union Budget 2021-22, an outlay of Rs 35,000 crore has been made towards COVID-19 vaccination and a commitment to provide further funds, if required, has also been expressed.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Health MinistryCoronavirus Vaccinehealth careIndian Economy

First Published: Mar 08 2021 | 8:40 PM IST

Next Story